Temporal modeling predicts tau onset age in Alzheimer's Disease, suggesting accessible clinical assessment tools.
Temporal modeling of plasma biomarkers provides comparable information to PET-based models, particularly for tau onset age, and can serve as a widely accessible tool for clinical assessment of biological disease severity. ANN NEUROL 2026.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: